Tirone David valve-sparing aortic root replacement: Equivalent mid-term outcome for different valve types with or without connective tissue disorder.

Department of Cardiovascular and Thoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
The Journal of thoracic and cardiovascular surgery (Impact Factor: 4.17). 10/2012; 145(1). DOI: 10.1016/j.jtcvs.2012.09.013
Source: PubMed

ABSTRACT Objective:
Although implicitly accepted by many that the durability of valve-sparing aortic root replacement in patients with bicuspid aortic valve disease and connective tissue disorders will be inferior, this hypothesis has not been rigorously investigated.

From 1993 to 2009, 233 patients (27% bicuspid aortic valve, 40% Marfan syndrome) underwent Tirone David valve-sparing aortic root replacement. Follow-up averaged 4.7 ± 3.3 years (1102 patient-years). Freedom from adverse outcomes was determined using log-rank calculations.

Survival at 5 and 10 years was 98.7% ± 0.7% and 93.5% ± 5.1%, respectively. Freedom from reoperation (all causes) on the aortic root was 92.2% ± 3.6% at 10 years; 3 reoperations were aortic valve replacement owing to structural valve deterioration. Freedom from structural valve deterioration at 10 years was 96.1% ± 2.1%. No significant differences were found in survival (P = .805, P = .793, respectively), reoperation (P = .179, P = .973, respectively), structural valve deterioration (P = .639, P = .982, respectively), or any other functional or clinical endpoints when patients were stratified by valve type (tricuspid aortic valve vs bicuspid aortic valve) or associated connective tissue disorder. At the latest echocardiographic follow-up (95% complete), 202 patients (94.8%) had none or trace aortic regurgitation, 10 (4.7%) mild, 0 had moderate to severe, and 1 (0.5%) had severe aortic regurgitation. Freedom from greater than 2+ aortic regurgitation at 10 years was 95.3% ± 2.5%. Six patients sustained acute type B aortic dissection (freedom at 10 years, 90.4% ± 5.0%).

Tirone David reimplantation valve-sparing aortic root replacement in carefully selected young patients was associated with excellent clinical and echocardiographic outcome in patients with either a tricuspid aortic valve or bicuspid aortic valve. No demonstrable adverse influence was found for Marfan syndrome or connective tissue disorder on durability, clinical outcome, or echocardiographic results.

Download full-text


Available from: Fabian A Kari, Jun 13, 2014
30 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Menschen mit Marfan-Syndrom stellen ein anspruchsvolles Patientenkollektiv in der herzchirurgischen Praxis dar. Aufgrund eigener guter Erfahrung mit dem klappenerhaltenden Aortenwurzelersatz (David-Operation) bei Patienten mit Marfan-Syndrom kann die frühzeitige prophylaktische Versorgung der Aorta angeraten werden. Eine Dissektion der Aorta muss aufgrund hoher initialer Letalität und vielfältiger später Komplikationen vermieden werden. Neue Hoffnung zur Vermeidung der Aortenerweiterung liegt in der Gabe von Sartanen, da diese den pathogenetisch entscheidenden „Transforming-growth-factor“(TGF)-β-Signalweg blockieren können.
    Zeitschrift für Herz- Thorax- und Gefäßchirurgie 04/2013; 27(2). DOI:10.1007/s00398-012-0986-7
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aortic valve sparing operations were developed to preserve the native aortic valve during surgery for aortic root aneurysm as well as surgery for ascending aortic aneurysms with associated aortic insufficiency. There are basically two types of aortic valve sparing oprations: remodeling of the aortic root and reimplantation of the aortic valve. These operations have been performed for over two decades and the clinical outcomes have been excellent in experienced hands. Although remodeling of the aortic root is physiologically superior to reimplantation of the aortic valve, long-term follow-up suggests that the latter is associated with lower risk of developing aortic insufficiency. Failure of remodeling of the aortic root is often due to dilatation of the aortic annulus. Thus, this type of aortic valve sparing should be reserved for older patients with ascending aortic aneurysm and normal aortic annulus whereas reimplantation of the aortic valve is more appropriate for young patients with inherited disorders that cause aortic root aneurysms. This article summarizes the published experience with these two operations. They are no longer experimental procedures and should be part of the surgical armamentarium to treat patients with aortic root aneurysm and ascending aortic aneurysms with associated aortic insufficiency.
    Korean Journal of Thoracic and Cardiovascular Surgery 08/2012; 45(4):205-12. DOI:10.5090/kjtcs.2012.45.4.205
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Individuals with Marfan syndrome constitute a challenging group of patients in cardiovascular surgical practice. Given own positive experience and recent reports using valve-sparing aortic root replacement (David procedure) in these patients, an early prophylactic surgical management of the aortic root seems to be a reasonable approach to avoid dissection, which is accompanied by high mortality and morbidity. New pharmaceuti- cal approaches to avoid aneurysm development include losartan, which interacts with transforming growth factor (TGF) beta signaling pathways.
Show more